Form 8-K - Current report:
SEC Accession No. 0001104659-09-068657
Filing Date
2009-12-07
Accepted
2009-12-07 06:07:50
Documents
2
Period of Report
2009-12-01
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a09-34928_18k.htm 8-K 21277
2 EX-3.1 a09-34928_1ex3d1.htm EX-3.1 27898
  Complete submission text file 0001104659-09-068657.txt   50962
Mailing Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 203823853 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-131722 | Film No.: 091224879
SIC: 2834 Pharmaceutical Preparations